UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2022-08-09 | 0.00 | 0.00 |
| Q1 2022 | 2022-05-05 | 0.00 | 0.00 |
| Q4 2021 | 2022-03-31 | -0.08 | -0.08 |
| Q1 2021 | 2022-03-24 | 0.00 | 0.00 |
| Q4 2020 | 2022-03-21 | 0.00 | 0.00 |
| Q3 2020 | 2021-11-08 | -0.11 | -0.11 |
| Q2 2020 | 2021-08-09 | -0.13 | -0.13 |
| Q1 2020 | 2021-04-29 | -0.14 | -0.14 |
| Q4 2019 | 2021-03-01 | -2.11 | -2.11 |
| Q2 2019 | 2019-08-05 | 0.00 | 0.00 |
| 2016-06-01 | Initiated Coverage | Wedbush | Outperform | $6.00 |
| 2016-05-10 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-03-12 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-12 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-03-03 | Reiterated Rating | Wedbush | Outperform | $6.00 |
| 2016-01-05 | Initiated Coverage | Wedbush | Outperform | $6.00 |
| 2015-12-07 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-11-30 | Reiterated Rating | Piper Jaffray | Buy | $7.00 |
| 2015-11-25 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-06-25 | Reiterated Rating | Cowen and Company | Outperform | |
| 2015-06-15 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $6.00 |
| 2015-06-11 | Reiterated Rating | Cowen and Company | Outperform | |
| 2014-03-03 | Initiated | Cowen | Outperform | |
| 2014-03-03 | Initiated Coverage | Cowen and Company | Outperform | |
| 2010-03-24 | Upgrade | Rodman & Renshaw | Mkt Perform to Mkt Outperform | $10 |
| 2008-11-21 | Initiated | Noble Financial | Buy | |
| 2008-10-27 | Upgrade | Susquehanna Financial | Negative to Neutral | |
| 2008-05-07 | Downgrade | Janney Mntgmy Scott | Buy to Neutral |
| 2016-06-01 | Initiated Coverage | Wedbush | Outperform | $6.00 |
| 2016-05-10 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-03-12 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-12 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-03-03 | Reiterated Rating | Wedbush | Outperform | $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In IDRA 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Pillar Pharmaceuticals I LP | 7.48% (6266175) | IDRA / |
| Senator Investment Group LP | 3.25% (2724700) | ATNY / IDRA / TSRE / |
| BAKER BROS. ADVISORS LP | 0.74% (616216) | ACAD / AQXP / BCRX / GHDX / IDRA / INCY / MRTX / SGEN / XOMA / |
| ZEIN YOUSSEF EL | 0.64% (539410) | IDRA / |
| GERAGHTY JAMES A | 0.52% (435369) | CBRX / IDRA / |
| MILANO VINCENT President and CEO | 0.29% (246527) | IDRA / VNDA / VPHM / |
| BAKER JULIAN | 0.15% (125179) | GEVA / IDRA / INCY / |
| HARTLEY C KEITH | 0.11% (92434) | IDRA / OLED / |
| REARDON WILLIAM S | 0.04% (32973) | HQH / HQL / IDRA / SNTA / |
| Sullivan Timothy M VP Development Programs | 0.03% (24914) | IDRA / |
| GOWEN MAXINE | 0.02% (17543) | AKBA / IDRA / TRVN / |
| KARR ROBERT W | 0.01% (6299) | IDRA / |
UM